Recruiting

Wearable Technology

Sponsor:

University of Kansas Medical Center

Code:

NCT03566836

Conditions

Atrial Fibrillation

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Garmin Smart Watch

Garmin Chest Band

Study Details

Brief summary:

The purpose of this study is to evaluate the feasibility of detecting atrial fibrillation (AF) in patients with AF using a wearable wrist device/smart watch.

Conditions

Atrial Fibrillation

Study ID

NCT03566836

Start date

Jun 19, 2018

Status verified date

Sep, 2019

Completion date

Jan, 2020

Anticipated

Primary completion date

Jan, 2020

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • All patients with AF scheduled to undergo electrical cardioversion at the University of Kansas Health System

Exclusion Criteria:

  • Patients with no detectable PPG
  • Hemodynamically unstable patients
  • Patients who cannot give informed consent
  • Patients with tattoos on the wrists

Study Design

Enrollment

120 participants

Anticipated

Interventions and Outcome Measures

Arms

AF Detection

Participants will be asked to wear the Garmin smart watch and Garmin chest band. Both are commercially available. The devices will collect information about heart rates before and after a cardioversion procedure.

Interventions

Garmin Smart Watch

Garmin Smart Watch

Garmin Chest Band

Garmin Chest Band

Primary outcome measure

  • Sensitivity and specificity of Garmin wearable device in detecting AF [ Time Frame: Visit 1 ]

Central Contacts and Locations

Central contacts

Locations

University of Kansas Medical Center

Recruiting

Kansas City, Kansas, United States, 66160

More Information

Sponsor

University of Kansas Medical Center

Last update posted

Sep 4, 2019

Last verified

Sep, 2019

Keywords

  • Smart Watch
  • Garmin
  • Wearable
  • Cardioversion

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Kansas Medical Center on 2019-09-04.